Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma – guidance (TA695)

Carfilzomib plus lenalidomide and dexamethasone is recommended as an option for treating multiple myeloma in adults, only if they have had only 1 previous therapy, which included bortezomib.

National Institute for Health and Care Excellence